The clinical program of CLL is quite heterogeneous, ranging from a reasonably asymptomatic condition which will even regress spontaneously to some progressive disorder that ultimately brings about the affected person’s Dying, so there has generally been extraordinary interest in pinpointing the prognosis of specific sufferers. While quite a few p